nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.346	0.735	CbGbCtD
Afatinib—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.125	0.265	CbGbCtD
Afatinib—ERBB2—kidney—focal segmental glomerulosclerosis	0.00625	0.153	CbGeAlD
Afatinib—ERBB4—cortex of kidney—focal segmental glomerulosclerosis	0.00609	0.149	CbGeAlD
Afatinib—DYRK1A—kidney—focal segmental glomerulosclerosis	0.00602	0.147	CbGeAlD
Afatinib—IRAK1—nephron tubule—focal segmental glomerulosclerosis	0.00532	0.13	CbGeAlD
Afatinib—Conjunctival hyperaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00467	0.101	CcSEcCtD
Afatinib—IRAK1—cortex of kidney—focal segmental glomerulosclerosis	0.00455	0.112	CbGeAlD
Afatinib—ABL1—nephron tubule—focal segmental glomerulosclerosis	0.00298	0.073	CbGeAlD
Afatinib—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.0029	0.0627	CcSEcCtD
Afatinib—ABL1—kidney—focal segmental glomerulosclerosis	0.00262	0.0642	CbGeAlD
Afatinib—ABL1—cortex of kidney—focal segmental glomerulosclerosis	0.00255	0.0625	CbGeAlD
Afatinib—Vandetanib—ALB—focal segmental glomerulosclerosis	0.00222	0.513	CrCbGaD
Afatinib—Gefitinib—ALB—focal segmental glomerulosclerosis	0.00211	0.487	CrCbGaD
Afatinib—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.00188	0.0461	CbGeAlD
Afatinib—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.0385	CcSEcCtD
Afatinib—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0339	CcSEcCtD
Afatinib—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.0295	CcSEcCtD
Afatinib—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0259	CcSEcCtD
Afatinib—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.0252	CcSEcCtD
Afatinib—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.025	CcSEcCtD
Afatinib—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0248	CcSEcCtD
Afatinib—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0248	CcSEcCtD
Afatinib—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0244	CcSEcCtD
Afatinib—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0242	CcSEcCtD
Afatinib—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0241	CcSEcCtD
Afatinib—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0241	CcSEcCtD
Afatinib—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0235	CcSEcCtD
Afatinib—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0234	CcSEcCtD
Afatinib—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.022	CcSEcCtD
Afatinib—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0219	CcSEcCtD
Afatinib—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0219	CcSEcCtD
Afatinib—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000929	0.0201	CcSEcCtD
Afatinib—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000927	0.0227	CbGeAlD
Afatinib—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000911	0.0197	CcSEcCtD
Afatinib—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000903	0.0195	CcSEcCtD
Afatinib—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000897	0.0194	CcSEcCtD
Afatinib—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000879	0.019	CcSEcCtD
Afatinib—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000863	0.0187	CcSEcCtD
Afatinib—ABCB1—kidney—focal segmental glomerulosclerosis	0.000815	0.02	CbGeAlD
Afatinib—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000793	0.0194	CbGeAlD
Afatinib—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000783	0.0169	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000759	0.0164	CcSEcCtD
Afatinib—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000728	0.0157	CcSEcCtD
Afatinib—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000718	0.0155	CcSEcCtD
Afatinib—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000711	0.0154	CcSEcCtD
Afatinib—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000662	0.0143	CcSEcCtD
Afatinib—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000653	0.0141	CcSEcCtD
Afatinib—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000645	0.0139	CcSEcCtD
Afatinib—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000637	0.0138	CcSEcCtD
Afatinib—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000632	0.0137	CcSEcCtD
Afatinib—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000631	0.0137	CcSEcCtD
Afatinib—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000626	0.0135	CcSEcCtD
Afatinib—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000579	0.0125	CcSEcCtD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000542	0.00124	CbGpPWpGaD
Afatinib—EGFR—LPA receptor mediated events—MMP9—focal segmental glomerulosclerosis	0.000541	0.00124	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000536	0.00122	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—PCNA—focal segmental glomerulosclerosis	0.000534	0.00122	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000533	0.00122	CbGpPWpGaD
Afatinib—LCK—B Cell Activation—CD79A—focal segmental glomerulosclerosis	0.000531	0.00121	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00053	0.00121	CbGpPWpGaD
Afatinib—EGFR—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.000528	0.00121	CbGpPWpGaD
Afatinib—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000525	0.0114	CcSEcCtD
Afatinib—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000518	0.0112	CcSEcCtD
Afatinib—EGFR—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000514	0.00117	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.00051	0.00117	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000505	0.00115	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000501	0.00114	CbGpPWpGaD
Afatinib—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.0108	CcSEcCtD
Afatinib—ABL1—Regulation of Telomerase—TGFB1—focal segmental glomerulosclerosis	0.000497	0.00114	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000495	0.00113	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000487	0.00111	CbGpPWpGaD
Afatinib—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000484	0.0105	CcSEcCtD
Afatinib—EGFR—EGF/EGFR Signaling Pathway—PCNA—focal segmental glomerulosclerosis	0.000475	0.00108	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.000467	0.00107	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000467	0.00107	CbGpPWpGaD
Afatinib—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000466	0.0101	CcSEcCtD
Afatinib—PHKG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000462	0.00105	CbGpPWpGaD
Afatinib—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000462	0.00999	CcSEcCtD
Afatinib—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000461	0.00998	CcSEcCtD
Afatinib—ERBB2—Immune System—MYH9—focal segmental glomerulosclerosis	0.00046	0.00105	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000459	0.00105	CbGpPWpGaD
Afatinib—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000459	0.00992	CcSEcCtD
Afatinib—EGFR—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000453	0.00103	CbGpPWpGaD
Afatinib—ERBB4—Immune System—MYH9—focal segmental glomerulosclerosis	0.000453	0.00103	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000452	0.00103	CbGpPWpGaD
Afatinib—IRAK1—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000449	0.00102	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000446	0.00102	CbGpPWpGaD
Afatinib—EGFR—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	0.000441	0.00101	CbGpPWpGaD
Afatinib—LCK—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000439	0.001	CbGpPWpGaD
Afatinib—BLK—Immune System—MYH9—focal segmental glomerulosclerosis	0.000435	0.000994	CbGpPWpGaD
Afatinib—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.00941	CcSEcCtD
Afatinib—BLK—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000435	0.000993	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000433	0.000989	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000432	0.000986	CbGpPWpGaD
Afatinib—EGFR—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.000432	0.000986	CbGpPWpGaD
Afatinib—EGFR—Focal Adhesion—SPP1—focal segmental glomerulosclerosis	0.000426	0.000973	CbGpPWpGaD
Afatinib—EGFR—Regulation of Telomerase—TGFB1—focal segmental glomerulosclerosis	0.000425	0.00097	CbGpPWpGaD
Afatinib—LCK—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	0.000425	0.00097	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00042	0.000959	CbGpPWpGaD
Afatinib—LCK—CXCR4-mediated signaling events—MMP9—focal segmental glomerulosclerosis	0.00042	0.000958	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000416	0.000951	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000416	0.000949	CbGpPWpGaD
Afatinib—PHKG2—Disease—LPL—focal segmental glomerulosclerosis	0.000415	0.000947	CbGpPWpGaD
Afatinib—EPHA6—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000413	0.000944	CbGpPWpGaD
Afatinib—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000413	0.000943	CbGpPWpGaD
Afatinib—ERBB2—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000407	0.000929	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000401	0.000916	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000395	0.000902	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000392	0.000896	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00039	0.00089	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—MMP2—focal segmental glomerulosclerosis	0.000385	0.000879	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000385	0.000878	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000382	0.000873	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000381	0.000871	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—SERPINE1—focal segmental glomerulosclerosis	0.000378	0.000862	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000374	0.000855	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000369	0.000842	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000369	0.000842	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000368	0.000839	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000363	0.000829	CbGpPWpGaD
Afatinib—ABL1—Cell Cycle—TGFB1—focal segmental glomerulosclerosis	0.000359	0.000821	CbGpPWpGaD
Afatinib—EGFR—Focal Adhesion—FN1—focal segmental glomerulosclerosis	0.000356	0.000812	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000355	0.00081	CbGpPWpGaD
Afatinib—ABL1—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000351	0.000802	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000349	0.000796	CbGpPWpGaD
Afatinib—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000348	0.000794	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—LPL—focal segmental glomerulosclerosis	0.000347	0.000793	CbGpPWpGaD
Afatinib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—focal segmental glomerulosclerosis	0.000341	0.000778	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000333	0.00076	CbGpPWpGaD
Afatinib—IRAK1—Immune System—MYH9—focal segmental glomerulosclerosis	0.000332	0.000759	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000332	0.000757	CbGpPWpGaD
Afatinib—PHKG2—Disease—NOS2—focal segmental glomerulosclerosis	0.000324	0.00074	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00032	0.00073	CbGpPWpGaD
Afatinib—LCK—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000315	0.000719	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000311	0.000711	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000307	0.000701	CbGpPWpGaD
Afatinib—ERBB2—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000306	0.000698	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000304	0.000693	CbGpPWpGaD
Afatinib—EGFR—Immune System—PIAS1—focal segmental glomerulosclerosis	0.0003	0.000685	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—AGT—focal segmental glomerulosclerosis	0.000297	0.000679	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000295	0.000673	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.00029	0.000663	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00029	0.000662	CbGpPWpGaD
Afatinib—LCK—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000289	0.00066	CbGpPWpGaD
Afatinib—EGFR—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.000288	0.000657	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CD79A—focal segmental glomerulosclerosis	0.000278	0.000636	CbGpPWpGaD
Afatinib—LCK—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.000277	0.000633	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CD79A—focal segmental glomerulosclerosis	0.000274	0.000626	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000273	0.000624	CbGpPWpGaD
Afatinib—PHKG2—Disease—SERPINE1—focal segmental glomerulosclerosis	0.000273	0.000623	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000267	0.000609	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000264	0.000603	CbGpPWpGaD
Afatinib—BLK—Immune System—CD79A—focal segmental glomerulosclerosis	0.000264	0.000602	CbGpPWpGaD
Afatinib—LCK—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000263	0.000601	CbGpPWpGaD
Afatinib—ABL1—Immune System—MYH9—focal segmental glomerulosclerosis	0.00026	0.000594	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000253	0.000577	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000252	0.000576	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000245	0.00056	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000243	0.000555	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00023	0.000526	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000229	0.000523	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—ALB—focal segmental glomerulosclerosis	0.000228	0.000521	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000228	0.00052	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000227	0.000518	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000226	0.000515	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000225	0.000514	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000224	0.000512	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000224	0.000511	CbGpPWpGaD
Afatinib—EGFR—Immune System—MYH9—focal segmental glomerulosclerosis	0.000222	0.000507	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000222	0.000507	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000218	0.000498	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000218	0.000497	CbGpPWpGaD
Afatinib—BLK—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000215	0.000491	CbGpPWpGaD
Afatinib—LCK—Immune System—MYH9—focal segmental glomerulosclerosis	0.000214	0.000489	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000214	0.000488	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.00021	0.00048	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000209	0.000478	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000206	0.000471	CbGpPWpGaD
Afatinib—ERBB2—Disease—LPL—focal segmental glomerulosclerosis	0.000206	0.00047	CbGpPWpGaD
Afatinib—ERBB4—Disease—LPL—focal segmental glomerulosclerosis	0.000203	0.000463	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD79A—focal segmental glomerulosclerosis	0.000201	0.00046	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000197	0.000449	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000194	0.000443	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000191	0.000437	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.00019	0.000434	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00019	0.000434	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000189	0.000431	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000188	0.000429	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000187	0.000428	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000187	0.000427	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000186	0.000426	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000186	0.000425	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000181	0.000413	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.00018	0.000411	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000178	0.000407	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000175	0.0004	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000174	0.000398	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000173	0.000395	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000173	0.000394	CbGpPWpGaD
Afatinib—PHKG2—Disease—TGFB1—focal segmental glomerulosclerosis	0.000172	0.000393	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000172	0.000392	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000166	0.000378	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000165	0.000376	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000164	0.000375	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000164	0.000375	CbGpPWpGaD
Afatinib—ERBB2—Disease—NOS2—focal segmental glomerulosclerosis	0.000161	0.000367	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000159	0.000364	CbGpPWpGaD
Afatinib—ERBB4—Disease—NOS2—focal segmental glomerulosclerosis	0.000158	0.000361	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000158	0.000361	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000158	0.00036	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD79A—focal segmental glomerulosclerosis	0.000158	0.00036	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000157	0.000358	CbGpPWpGaD
Afatinib—LCK—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000156	0.000357	CbGpPWpGaD
Afatinib—LCK—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000155	0.000353	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000151	0.000344	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000148	0.000339	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000148	0.000338	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000146	0.000334	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000145	0.000331	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000144	0.000329	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000143	0.000327	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000143	0.000326	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000142	0.000324	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.00014	0.000321	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000138	0.000316	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000136	0.000312	CbGpPWpGaD
Afatinib—ERBB2—Disease—SERPINE1—focal segmental glomerulosclerosis	0.000135	0.000309	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD79A—focal segmental glomerulosclerosis	0.000135	0.000307	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000134	0.000307	CbGpPWpGaD
Afatinib—ERBB4—Disease—SERPINE1—focal segmental glomerulosclerosis	0.000133	0.000304	CbGpPWpGaD
Afatinib—LCK—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.00013	0.000297	CbGpPWpGaD
Afatinib—LCK—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00013	0.000297	CbGpPWpGaD
Afatinib—LCK—Immune System—CD79A—focal segmental glomerulosclerosis	0.00013	0.000296	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000128	0.000293	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000127	0.000291	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000127	0.000289	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000123	0.000282	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000123	0.000281	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000122	0.000277	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000121	0.000277	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000114	0.00026	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000112	0.000256	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000112	0.000256	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000111	0.000253	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00011	0.000251	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD40LG—focal segmental glomerulosclerosis	0.00011	0.000251	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000109	0.000249	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000107	0.000245	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000107	0.000244	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000106	0.000242	CbGpPWpGaD
Afatinib—LCK—Immune System—CD40LG—focal segmental glomerulosclerosis	0.000106	0.000241	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—MMP9—focal segmental glomerulosclerosis	0.000106	0.000241	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000104	0.000238	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000103	0.000236	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	0.000102	0.000232	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000101	0.00023	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—TGFB1—focal segmental glomerulosclerosis	9.98e-05	0.000228	CbGpPWpGaD
Afatinib—EGFR—Disease—LPL—focal segmental glomerulosclerosis	9.94e-05	0.000227	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.86e-05	0.000225	CbGpPWpGaD
Afatinib—LCK—Disease—LPL—focal segmental glomerulosclerosis	9.58e-05	0.000219	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.48e-05	0.000216	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	9.39e-05	0.000214	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.33e-05	0.000213	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.26e-05	0.000211	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	8.92e-05	0.000204	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.91e-05	0.000203	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	8.7e-05	0.000199	CbGpPWpGaD
Afatinib—ERBB2—Disease—TGFB1—focal segmental glomerulosclerosis	8.54e-05	0.000195	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.47e-05	0.000193	CbGpPWpGaD
Afatinib—ERBB4—Disease—TGFB1—focal segmental glomerulosclerosis	8.41e-05	0.000192	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.23e-05	0.000188	CbGpPWpGaD
Afatinib—LCK—Hemostasis—TGFB1—focal segmental glomerulosclerosis	8.22e-05	0.000188	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.16e-05	0.000186	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	7.78e-05	0.000178	CbGpPWpGaD
Afatinib—EGFR—Disease—NOS2—focal segmental glomerulosclerosis	7.77e-05	0.000177	CbGpPWpGaD
Afatinib—LCK—Disease—NOS2—focal segmental glomerulosclerosis	7.49e-05	0.000171	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.26e-05	0.000166	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.18e-05	0.000164	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.15e-05	0.000163	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.96e-05	0.000159	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.92e-05	0.000158	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	6.89e-05	0.000157	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.85e-05	0.000156	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.71e-05	0.000153	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	6.65e-05	0.000152	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.6e-05	0.000151	CbGpPWpGaD
Afatinib—EGFR—Disease—SERPINE1—focal segmental glomerulosclerosis	6.54e-05	0.000149	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.36e-05	0.000145	CbGpPWpGaD
Afatinib—LCK—Disease—SERPINE1—focal segmental glomerulosclerosis	6.3e-05	0.000144	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	6.06e-05	0.000138	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.98e-05	0.000137	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.96e-05	0.000136	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.89e-05	0.000135	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.89e-05	0.000135	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.74e-05	0.000131	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.59e-05	0.000128	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.5e-05	0.000126	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.31e-05	0.000121	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.25e-05	0.00012	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	5.1e-05	0.000117	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.58e-05	0.000105	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.41e-05	0.000101	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.32e-05	9.88e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	4.2e-05	9.6e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—TGFB1—focal segmental glomerulosclerosis	4.13e-05	9.43e-05	CbGpPWpGaD
Afatinib—LCK—Disease—TGFB1—focal segmental glomerulosclerosis	3.98e-05	9.09e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	3.6e-05	8.21e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.51e-05	8.01e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.38e-05	7.72e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.89e-05	6.6e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.79e-05	6.36e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	2.76e-05	6.3e-05	CbGpPWpGaD
